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The usefulness of nanotechnology for biotechnological applications is frequently emphasized. The
recent development for using nanostructured materials as supports for free-standing lipid bilayers is
brieﬂy reviewed. The authors then demonstrate that the stability of fragile free-standing lipid
bilayers in nanopores is enhanced up to days depending on the surface chemistry, the lipid
composition, and the diameter of the pores. The insertion of a pore forming protein into bilayers can
be monitored over time as a stepwise decrease of membrane resistance. Since membrane proteins
are major drug targets, such stable and functional proteo-bilayers integrated in microﬂuidics are the
key components of in vitro devices for drug screening. This conference paper reviews the recent
literature and provides preliminary results from own research. © 2008 American Vacuum Society.
DOI: 10.1116/1.2912932
I. REVIEWING RESEARCH ON SUPPORTED
LIPID BILAYERS
A. Motivation for research
From a chemical point of view the idea of life is the
separation of microscopic aqueous chambers by lipid bilay-
ers to enable complex concerted biochemical reactions. The
main internal reaction chamber of a cell, the cytoplasm, is
separated from the outside world by such a membrane,
which consists of a typical lipid composition. Furthermore,
bilayers form compartments within the cell, which carry out
various functions, i.e., energy production in mitochondria,
formation of new cellular structures in the endoplasmic
reticulum, and controlled degradation of metabolic and struc-
tural biomolecules in lysosomes. Lipids spontaneously self-
assemble in an aqueous environment due to their amphiphilic
nature. However, biological membranes are much more than
simple lipid bilayers.1 Integrated proteins can act as gates
and selectively transport ions across these barriers; others
regulate metabolic reactions or communicate with the out-
side world. The complex interaction and dynamic regulation
of membrane proteins is presently poorly understood and is a
major topic of systems biology.2
Genome analysis dramatically extended our knowledge
about membrane proteins. From the human genome se-
quence analysis the number of membrane proteins can be
assessed to about 8000, which is approximately 30% of all
human genes. The majority of membrane proteins have sev-
eral hydrophobic helical domains, which span lipid bilayers.
This structural motive has been deduced from x-ray diffrac-
tion patterns of protein crystals. The atomic 3D structure
allows us to understand protein functions. However, the crys-
tallization of membrane proteins is very difﬁcult. In addition,
post-translational modiﬁcations occur in mammalian cells re-
sulting in glycosylated proteins, which are even more difﬁ-
cult to crystallize. Thus, from the 176 presently known
unique membrane protein structures Aug. 2007, less than
10 from homo sapiens are of a sufﬁciently high resolution to
understand their function.3 These represent only about 1% of
the current 1160 membrane protein families, which can be
categorized according to their function in receptors, trans-
porters, ion channels, pumps, signal transducers, lipid meta-
bolic enzymes transferases, mitochondrial oxidase, and
structure proteins nuclear porins.4 This illustrates the im-
portance of membrane proteins in sustaining life functions.
Modern biology and molecular medicine aimed at under-
standing the dynamic processes of life at a molecular level.
Therefore, it is of pivotal importance to understand quantita-
tively the binding processes of natural effectors, i.e., of hor-
mones and metabolic species to membrane proteins. Such
data provide the basic knowledge that enables us to modulate
their function. For an effective selection and design of arti-
ﬁcial effector compounds, both structural information and
quantitative analytical methods are required. Thus, functional
assays for membrane proteins are needed to screen libraries
of effector compounds that contain potentially useful drug
candidates. Such versatile assay systems have a high com-
mercial potential, since membrane proteins are main drug
targets. In summary, for research as well as for drug devel-
opment robust, simple and cheap assay systems are required
for measuring the function of membrane proteins.
B. State-of-the art of supported bilayer systems
Membrane proteins are macromolecules consisting of a
linear polyamide backbone chain of 100 up to 1000 con-
densed amino acids and their side-chains. The backbone
forms to a great extent secondary structures such as alpha-
helixes and beta-sheets, which are further combined to
domains.5 Such functional domains are rather rigid when as-
sembled in bundles of alpha-helices or in sandwiches. The
interaction between structural elements of the domains is the
basic principle for the speciﬁc function of membrane pro-aElectronic mail: louis.tiefenauer@psi.ch
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teins. For instance, the conformational changes of amino
acid residues in the selectivity ﬁlter of a K+ channel6 result in
a dislocation of pore helices and an opening of the vestibule
followed by a speciﬁc ﬂow of the K+ ions across the embed-
ded macromolecule. Thus, a sufﬁciently high ﬂexibility is
often a prerequisite for the function of an integrated mem-
brane protein.7 The snuggling of lipids to the proteins em-
bedded in ﬂuid bilayer membranes is poorly understood, but
is often of pivotal importance for their function.8 Therefore
artiﬁcial bilayers must retain the high ﬂexibility of the inte-
grated proteins.
In the fundamental work of Müller9,10 and Montal11 planar
lipid bilayers were formed on supports with a small aperture
0.1−1 mm, which separate two compartments. Addition of
liposomes to the buffer in the compartments results in spread
lipid monolayers at the air-water interface. When the buffer
levels are raised alternatingly above the aperture, a lipid bi-
layer is formed Fig. 1. Such so-called black lipid mem-
branes BLMs were very helpful to investigate the effect of
peptides integrating into bilayers.12,13 Since BLMs are noto-
riously fragile,14 a race began in the late 1980s to make them
more stable. Several groups started to immobilize lipid bilay-
ers on solid surfaces,15–17 aimed at achieving systems suit-
able for analytical applications.18 In developing stable and
functional supported bilayers, one main topic of the TETH-
MEM conference meetings, researchers encountered the dif-
ﬁculties of squaring the circle. A stabilized bilayer is rigid
and consequently not suitable to keep membrane proteins in
a functional state, whereas bilayers of natural lipid mobility
are usually not stable enough. The lateral mobility of lipids
in the bilayer is calculated from the recovery time of ﬂuo-
rescent dye-labeled lipids required to reﬁll a small pho-
tobleached spot in the bilayer.19 In order to achieve stable
and ﬂuid lipid membranes, chemists have synthesized new
organic molecules to bind lipid bilayers on surfaces by mo-
lecular tethers.20–23 Alternatively, thin hydrophilic polymer
ﬁlms have been spread on the surface to generate a small
aqueous gap between the bilayer and the surface.24,25 It could
be shown that the mobility of lipids in such molecular con-
structions is comparable to that of biological membranes and
that even membrane proteins can be integrated in a func-
tional state.17,26–29 However, a major drawback remains for
analytical applications: The very small space between the
bilayer and the support about 2 to 10 nm is rapidly satu-
rated by the transported species.30 This makes quantitative
dynamic measurements difﬁcult.
The great potential of emerging micro- and nanofabrica-
tion methods for topologically structuring surfaces was rec-
ognized about 10 years ago31 and the expectations for bio-
analytical applications are promising.32 When free-standing
planar lipid bilayers are spanned over nanopores, their sta-
bility will presumably be enhanced and both sides are acces-
sible Fig. 2. Since such nano-BLMs strongly resemble
BLMs in apertures of micrometer dimensions in Teﬂon
sheets, the biophysical properties, especially the ﬂuidity of
the membrane will be similar.
C. Recent research activities using nanostructured
supports
In the last 5 years different nanostructured surfaces were
used as supports for lipid bilayers.33 Painting lipids on single
microfabricated pores with diameters of 50 to 200 m re-
sulted in free-standing lipid bilayers to which, in a second
step, proteoliposomes have been fused by using a glass rod.
From such micro-BLMs the activity of integrated ion chan-
nel proteins could be recorded.34 The authors found an in-
crease of the speciﬁc capacitance with smaller pore sizes up
to a factor of 2 and explained this by a higher fraction of
bilayer compared to other systems where a larger solvent
torus, the so-called annulus,35 is observed. On hydrophobic
FIG. 1. The formation of planar lipid bilayers can be achieved by four
different methods as sketched. Functional membrane proteins will be inte-
grated in planar bilayers either by fusion of proteo-liposomes to preformed
bilayers or by direct fusion of proteo-liposomes to nanopores. Using these
methods the surface density of membrane proteins can easily be controlled.
The Müller-Montal method is used to prepare and investigate the stability of
planar proteo-bilayers as presented in Fig. 5.
FIG. 2. Free-standing planar lipid bilayers in one pore of a nanopore array
support for functional assays of membrane proteins. As a typical membrane
protein the ammonium transporter AmtB Ref. 63 green and the inhibitor
GlnK Ref. 64 blue are shown, which regulate the passage of ammonium/
ammonia molecules small circles from cis- to trans-side of the membrane.
Note that the three loops of GlnK closely interact with AmtB and a free
access at the trans-side is required.
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surfaces the organic solvent is presumably excluded to a
higher degree. It remains unclear if the observed increased
capacitance is attributed to the surface chemistry or to the
pore size. In a systematic study comparing planar free-
standing bilayers on Teﬂon chips with pore diameters rang-
ing from 25 to 250 m diameter,36 the speciﬁc capacitance
of the bilayers was almost constant at about 0.6 F cm−2, a
value reported for BLMs9 and tethered bilayers.37 Such bi-
layers are stable for many hours even at applied voltages up
to 400 mV. The ion channel activity of alamethicin and
alpha-hemolysin -HL could be recorded at a high signal
to noise S/N ratio. The advantage of a high S/N ratio was
also observed for bilayers generated by painting lipids on
single micropores of 5 to 500 m diameter in Teﬂon
sheets.38 However, the stability of such bilayers was limited
to about 1 h under the applied potential of 150 mV. The
authors38 concluded that recording from multiple planar lipid
bilayers in parallel would be an attractive approach for high
throughput screening. A remarkable increase of stability of
DPhPC-bilayers in micropores using an agarose gel has re-
cently been reported.39
Polycarbonate membranes as used for ultraﬁltration are a
commercial source for nanoporous supports. The pores in
these membranes are of uniform size of about 1 m and
they are irregularly arranged.40 Such polycarbonate mem-
branes have been covered with a gold layer to which thi-
olated alkane molecules were immobilized. After immersion
into a phosphatidylcholine PC solution, free-standing bilay-
ers were spontaneously formed in the pores and the effect of
ion carrier insertion as well as the activity of the ionotropic
glutamate receptor were recorded.41 However, the stability of
the PC-bilayers was only about half an hour and could be
enhanced to about 10 h with 25% cholesterol. Although the
feasibility of functional assays for membrane proteins has
been demonstrated,40,41 ultraﬁltration membranes have some
severe limitations: 1 The achieved sealing of about
10 M cm2 is too low for sensitive measurements;33 2 the
pore density is rather low; 3 the pore distribution is ran-
dom, resulting in merged pores in which bilayer stability
may be affected; 4 the membrane is about 10 m thick,
leading to a high aspect ratio pore size to membrane thick-
ness and a hindered diffusion across the support as it can be
suggested from the slow response time; and 5 the stability
of coated gold on the polymer carbonate may be too low for
commercial applications.
Nanoporous alumina membranes were frequently used by
Steinem’s group to support free-standing lipid bilayers.42–46
The formation of bilayers was conﬁrmed by electrochemical
impedance spectroscopy EIS analysis. An adequate equiva-
lent circuit model is a prerequisite for ﬁtting the measured
data points aimed at providing resistance and capacitance
values of the membrane. These two main parameters allow
us to compare the quality of lipid bilayer preparations. For
complex preparations consisting of thin layers it is difﬁcult
to ﬁnd the adequate model, since the capacitance value is
indirectly proportional to the thickness of the layer, i.e., mo-
lecular lipid monolayers contribute much more to the capaci-
tance value than the thicker support. Furthermore, it has to
be considered that the capacitance contributions of free-
standing bilayers in nanopores and of the parallel bilayers on
support between the pores are additive. Therefore, the exact
pore area has to be known for a precise calculation of the
speciﬁc bilayer capacitance. In their earlier work, the ex-
pected capacitance value of 10.2 F cm−2 was obtained
for bilayers formed from giant vesicles that fused to nanop-
ores of 20 and 50 nm diameter.42 In a further development
the nanoporous alumina supports have been coated with
gold, allowing the immobilization of thiolated lipids as an-
chors for lipid bilayers consisting of the plant lipid di-
phytanoyl-sn-glycero-3-phosphatidylcholine DPhPC. The
stability of the so-called nano-BLMs was monitored by de-
termining the membrane resistance value over time. The ini-
tial membrane resistance of 7 G drops to 2 M during
120 h. This high membrane resistance and the sufﬁciently
long stability permit measurements of single channels.43
Upon insertion of single bacterial outer membrane protein F
OmpF, trimers are formed in preformed nano-BLM on 60
nm pores and different opening states of OmpF channels
could be discriminated by current measurements. At a hold-
ing potential of −100 mV, steps of 170 pA currents have
been determined, and the corresponding conductance value
of 1.7 nS obtained by statistical analysis has been interpreted
as single ion channels.45 Smaller current steps were detected
during the so-called subconductance state and in the pres-
ence of the antibiotic ampicillin. These experiments show
that single transmembrane proteins can be monitored using
BLMs supported on nanoporous surfaces.
II. PRELIMINARY RESULTS USING NANOPORE
ARRAYS TO SUPPORT LIPID BILAYERS
Some years ago a high throughput fabrication technique
was reported for chips with a thin silicon nitride membrane
in which nanopores are arranged in regular arrays.47 Such
nanopore arrays in a silicon nitride membrane were hydro-
phobically functionalized and bilayers are formed by the
painting method Fig. 1. It was found that painted lipid bi-
layers were exceptionally stable.48 In a comparative study it
has been demonstrated that the stability of free standing bi-
layers on 800 nm pores depends on the nature of the lipid.
Bilayers formed from the cylindrically shaped phosphati-
dylethanolamine PE lipid exhibited a membrane resistance
above the high threshold of 1 G for more than 1 week.
Bilayers of the plant lipid DPhPC and the common lipid
1-palmitoyl-2-oleoyl PC POPC were above the threshold
for 2 days whereas bilayers of the naturally occurring soy PC
mixtures were stable for only about 2 h. By reducing the
pore size to 200 nm, the stability of POPC-bilayers was in-
creased by about 50%, whereas soy PC-bilayers were now
stable for 3 days, which is an increase by a factor of 30. A
high stability of natural lipid mixtures in nanopores is very
important, since most membrane proteins may require de-
ﬁned mixtures of lipids to remain functional. A frequently
used and relatively simple quality test for bilayers is the in-
sertion of ionophores. The functionality of DPhPC-bilayers
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on 800 nm pore arrays has been demonstrated by adding
valinomycin and subsequently increasing concentrations of
KCl, resulting in a gradual decrease of the membrane
resistance.48 Furthermore, formation of protein pores in pre-
formed POPC-bilayers can be monitored over time Fig. 3.
After a long lag time, which depends on the pore size and the
-HL concentration, the conductance of the lipid bilayer in-
creased by steps of 9 pA under the indicated conditions. This
value is in agreement with the reported single -HL pore
current of 7 pA determined at 30 mV and 250 mM KCl,49 a
recent study using variable conditions. The beneﬁt of using
nanopore arrays for monitoring single molecule signals may
rely on at least two factors: the stabilization of lipid bilayers
and the high S/N ratio as reported for small apertures38 as
conﬁrmed by the low observed noise see Fig. 3. For prac-
tical applications in drug screening the measurements of
multiple events resulting in higher signals may be required.
Nanopores as support for free-standing bilayers are prob-
ably useful for commercial functional assay systems of
membrane proteins. The ﬂuidity of the free-standing bilayers
within the pores is probably comparable to that of biological
membranes and as a consequence transmembrane proteins
will be mobile. The observed 30 times increase in stability
by reducing the pore size by a factor of 4 demonstrates the
beneﬁt from using nanostructures. From an extended system-
atic study Fig. 4 it can be concluded that a pore size
400 nm will probably be necessary to form stable lipid
bilayers of natural lipid mixtures. Thus, reliable and simple
methods for the fabrication of nanopore arrays support are
required.
In addition to a small pore diameter, a suitable surface
chemistry is required to stabilize free-standing bilayers.
Thiol-compounds strongly bind to the gold surface, resulting
in the observed high bilayer stability. However, the use of the
gold-thiol combination also has two major disadvantages: 1
Coating of gold and preferentially of an adhesion layer of Cr
are two additional steps. 2 The gold-thiol bond is prone to
degradation by oxidizing agents. For practical applications a
fast, simple, and reliable procedure is needed to form stable
planar proteo-bilayers. Peptides and pore forming membrane
proteins spontaneously insert into preformed bilayers. How-
ever, reconstitution of the majority of other membrane pro-
teins is demanding and their integration in bilayers is a major
challenge. The mentioned Müller-Montal method allows us
to form bilayers from lipid39 monolayer with integrated pro-
teins without using organic solvent to dissolve the lipids. We
found that bilayers formed from prokaryotic lipid mixtures in
this way were less stable than painted bilayers Fig. 5. Fur-
FIG. 3. Monitoring the formation of individual heptameric -hemolysin
pores in preformed painted planar POPC-bilayers present in 960 000 pores
of 200 nm diameter arranged in arrays.48 The current increases in steps of 9
pA after a long lag time. Experimental condition: 200 nM -hemolysin in
150 mM KCl at an applied voltage of 50 mV.
FIG. 4. Stability of bilayers of soy PC SPC, , ,  and POPC , , 
on nanopore arrays of different pore diameters 200 nm , , 400 , ,
and 800 nm ,  . The dotted line indicates the very high threshold of
1 G above which bilayers are present in all pores of the support. If only
one pore opens, the membrane resistance drops to 200 M data not
shown. Bilayers consisting of POPC are more stable than those of SPC,
which need a pore diameter of 400 nm  or smaller to maintain a sealing
above 1 G for 1 day.
FIG. 5. Stability of free-standing proteo-lipid bilayers generated from pro-
teoliposomes according to Müller and Montal.9 A sodium channel NaCh-
Bac from B. halodurans was reconstituted in a lipid mixture of E. coli using
beta-octyl glucoside and Biobeads for detergent depletion. The best of three
preparations for each condition are shown. Note the effect of the membrane
protein on the stability of the planar lipid bilayers.
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thermore, the stability of these bilayers is also higher in
smaller pores and when membrane proteins are integrated
therein see ∀ in Fig. 5. However, the preparation of func-
tional bilayers for screening applications must be much sim-
pler. The formation of stable bilayers upon addition of
proteo-liposomes to nanopore arrays should be achieved
within minutes. Although many groups reported about fusion
processes of proteo-liposomes to planar unstructured
supports,50–57 little is known about the inﬂuence of nanop-
ores on the fusion of proteoliposomes of a similar size see
Fig. 1. Again, the inﬂuence of liposome composition and
surface chemistry has to be investigated in a systematic way
to ﬁnd a suitable procedure for membrane protein immobili-
zation.
III. OUTLOOK
For practical applications, planar proteo-bilayers need to
be integrated in a system that allows 1 automated addition
of reagents, 2 continuous control of the bilayer membrane
quality, and 3 detection of the membrane protein activity
Fig. 6. Such automatic microﬂuidic systems have been de-
veloped for biosensors in general and recently also to gener-
ate lipid bilayers.58–62 The formation of bilayers can be
achieved by a controlled pumping of a low concentration of
the lipid dissolved in decane to the cis-side whereas the
trans-side is ﬁlled with electrolyte. Upon alamethicin and
-HL insertion into bilayers,60 signals with a high S/N ratio
have been recorded at a clamped voltage of 60 and 40 mV,
respectively.61 This experiment demonstrates that the men-
tioned three tasks can be performed by a relatively simple
microﬂuidic system buildup of the commonly used material
polymethylmethacrylate PMMA.
The free access to both sides as shown in Fig. 1 opens
new possibilities also for optical detection of molecules and
ions transported across lipid bilayers by a membrane protein
of interest. Since diffusion may not be impeded by nanopores
with a low aspect ratio, the transport of chemical species can
be visualized by measuring the ﬂuorescence of dyed mol-
ecules in the trans-compartment. The simultaneous measure-
ment of electrochemical and optical signals will signiﬁcantly
contribute to the understanding of transmembrane processes
as well as to a simple and reliable continuous quality control
of bilayers as required for screening applications.
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